Catalyst Wire Dossier Catalyst Wire Dossier

HMB (beta-hydroxy-beta-methylbutyrate)

beta-hydroxy-beta-methylbutyrate
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HMB (beta-hydroxy-beta-methylbutyrate), covering 2025-08-29 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes [Phase 2]

See pricing